A detailed history of Prio Wealth Limited Partnership transactions in Boston Scientific Corp stock. As of the latest transaction made, Prio Wealth Limited Partnership holds 849,816 shares of BSX stock, worth $69.3 Million. This represents 1.7% of its overall portfolio holdings.

Number of Shares
849,816
Previous 794,649 6.94%
Holding current value
$69.3 Million
Previous $45.9 Million 26.7%
% of portfolio
1.7%
Previous 1.59%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $3.18 Million - $3.79 Million
55,167 Added 6.94%
849,816 $58.2 Million
Q4 2023

Jan 22, 2024

SELL
$48.64 - $57.81 $929,802 - $1.11 Million
-19,116 Reduced 2.35%
794,649 $45.9 Million
Q3 2023

Oct 31, 2023

SELL
$50.19 - $54.68 $3.09 Million - $3.36 Million
-61,480 Reduced 7.02%
813,765 $43 Million
Q2 2023

Aug 08, 2023

SELL
$49.72 - $54.64 $10.9 Million - $12 Million
-220,076 Reduced 20.09%
875,245 $47.3 Million
Q1 2023

May 12, 2023

SELL
$45.09 - $50.03 $1.03 Million - $1.14 Million
-22,733 Reduced 2.03%
1,095,321 $54.8 Million
Q4 2022

Feb 13, 2023

SELL
$39.56 - $47.22 $1.66 Million - $1.98 Million
-41,982 Reduced 3.62%
1,118,054 $0
Q3 2022

Feb 27, 2023

BUY
$36.71 - $109.66 $406,636 - $1.21 Million
11,077 Added 0.97%
1,154,745 $44.7 Million
Q2 2022

Feb 27, 2023

BUY
$35.24 - $47.1 $902,637 - $1.21 Million
25,614 Added 2.29%
1,143,668 $42.6 Million
Q1 2022

Feb 21, 2023

BUY
$40.9 - $45.1 $2.25 Million - $2.49 Million
55,105 Added 4.93%
1,173,159 $52 Million
Q4 2021

Feb 17, 2022

BUY
$38.07 - $44.87 $297,517 - $350,659
7,815 Added 0.68%
1,160,036 $49.3 Million
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $673,450 - $749,403
16,334 Added 1.44%
1,152,221 $50 Million
Q2 2021

Aug 16, 2021

SELL
$38.58 - $44.24 $9,027 - $10,352
-234 Reduced 0.02%
1,135,887 $48.6 Million
Q1 2021

May 06, 2021

BUY
$35.27 - $39.67 $1.9 Million - $2.13 Million
53,731 Added 4.96%
1,136,121 $43.9 Million
Q4 2020

Feb 04, 2021

BUY
$33.15 - $41.97 $409,170 - $518,035
12,343 Added 1.15%
1,082,390 $38.9 Million
Q3 2020

Nov 16, 2020

BUY
$34.44 - $42.23 $672,303 - $824,371
19,521 Added 1.86%
1,070,047 $40.9 Million
Q2 2020

Aug 11, 2020

BUY
$30.19 - $39.11 $724,167 - $938,131
23,987 Added 2.34%
1,050,526 $36.9 Million
Q1 2020

May 13, 2020

SELL
$25.83 - $45.71 $117,629 - $208,163
-4,554 Reduced 0.44%
1,026,539 $33.5 Million
Q4 2019

Feb 10, 2020

BUY
$37.87 - $45.37 $427,438 - $512,091
11,287 Added 1.11%
1,031,093 $46.6 Million
Q3 2019

Nov 13, 2019

SELL
$40.31 - $43.45 $296,238 - $319,314
-7,349 Reduced 0.72%
1,019,806 $41.5 Million
Q2 2019

Jul 18, 2019

SELL
$34.91 - $42.98 $65,630 - $80,802
-1,880 Reduced 0.18%
1,027,155 $44.1 Million
Q1 2019

May 03, 2019

SELL
$32.91 - $40.75 $480,848 - $595,398
-14,611 Reduced 1.4%
1,029,035 $39.5 Million
Q4 2018

Feb 06, 2019

SELL
$31.73 - $39.04 $107,659 - $132,462
-3,393 Reduced 0.32%
1,043,646 $36.9 Million
Q3 2018

Nov 07, 2018

BUY
$32.83 - $38.63 $1.1 Million - $1.29 Million
33,407 Added 3.3%
1,047,039 $40.3 Million
Q2 2018

Aug 06, 2018

SELL
$26.84 - $34.32 $501,210 - $640,891
-18,674 Reduced 1.81%
1,013,632 $33.1 Million
Q1 2018

Apr 17, 2018

BUY
$25.2 - $28.54 $26 Million - $29.5 Million
1,032,306 New
1,032,306 $28.2 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $117B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Prio Wealth Limited Partnership Portfolio

Follow Prio Wealth Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prio Wealth Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Prio Wealth Limited Partnership with notifications on news.